🇺🇸 FDA
Pipeline program

Dupilumab Injectable Product

HSR200039

Approved small_molecule active

Quick answer

Dupilumab Injectable Product for Asthma is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Asthma
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials